e. lopez varela (Barcelona, Spain), J. Alves Junior (São Paulo (SP), Brazil)
Period and cohort effects: consequences on lung function in Norway during the 20th century
L. Cestelli (Bergen, Norway), A. Johannessen (Bergen, Norway), K. Stavem (Lørenskog, Norway), A. Gulsvik (Bergen, Norway), R. Nielsen (Bergen, Norway)
|   |
Associations between breast feeding and lung function in middle age
D. Bui (Melbourne (VIC), Australia), J. Perret (Melbourne (VIC), Australia), C. Lodge (Melbourne (VIC), Australia), A. Lowe (Melbourne (VIC), Australia), G. Bowatte (Melbourne (VIC), Australia), E. Bircan (Melbourne (VIC), Australia), A. James (Melbourne (VIC), Australia), M. Abramson (Melbourne (VIC), Australia), G. Hamilton (Melbourne (VIC), Australia), H. Walters (Melbourne (VIC), Australia), S. Dharmage (Melbourne (VIC), Australia)
| |
Supranormal lung function by age bins in the LEAD Study
C. Schiffers (Vienna, Austria), R. Faner (Barcelona, Spain), A. Ofenheimer (Vienna, Austria), P. Puchhammer (Vienna, Austria), M. Breyer (Vienna, Austria), O. Burghuber (Vienna, Austria), S. Hartl (Vienna, Austria), A. Agusti (Barcelona, Spain), R. Breyer-Kohansal (Vienna, Austria)
| |
Cardiovascular disease linked plasma proteins relate mainly to lung volumes
A. Rydell (Stockholm, Sweden), E. Nerpin (Uppsala, Sweden), X. Zhou (Uppsala, Sweden), L. Lind (Uppsala, Sweden), E. Lindberg (Uppsala, Sweden), J. Theorell Haglöw (Uppsala, Sweden), T. Fall (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), S. Elmståhl (Lund, Sweden), S. Zaigham (Lund, Sweden), O. Melander (Lund, Sweden), P. Nilsson (Lund, Sweden), M. Orhu-Melander (Lund, Sweden), J. Ärnlöv (Stockholm, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Associations of black carbon with lung function in COPD patients
O. Salimbene (Torino, Italy), I. Salimbene (Salerno, Italy), M. Zanetti (Torino, Italy), M. Ravina (Torino, Italy), D. Panepinto (Torino, Italy)
| |
Respiratory function in patients post-infection by COVID-19
W. MADI (Gabes, Tunisia), S. Majdoub Fehri (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), R. Sallami (Gabes, Tunisia), H. Kwass (Gabes, Tunisia)
| |
BMI increase – A determinant of FEV1 decline for overweight and obese adults with asthma
N. Bermudez Baron (Luleå, Sweden), H. Kankaanranta (Gothenburg, Tampere and Seinäjoki, Finland), L. Hedman (Luleå, Sweden), M. Andersson (Umeå, Sweden), C. Stridsman (Luleå, Sweden), A. Lindberg (Luleå, Sweden), E. Rönmark (Luleå, Sweden), H. Backman (Luleå, Sweden)
| |
Changes in COPD prevalence in Madrid from 2007 to 2017
E. Garcia Castillo (Madrid, Spain), T. Alonso Pérez (Madrid, Spain), J. Eiros Bachiller (Madrid, Spain), A. Peláez Laderas (Madrid, Spain), P. Pérez González (Madrid, Spain), E. Ávalos Pérez-Urría (Madrid, Spain), E. Martínez Besteiros (Madrid, Spain), J. B. Soriano (Madrid, Spain), J. Ancochea (Madrid, Spain)
| |
Incidence, prevalence and regional distribution of systemic sclerosis and associated interstitial lung disease: a nationwide cohort study
M. Knarborg (Vejle, Denmark), C. Hyldgaard (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark), J. Rømhild Davidsen (Odense, Denmark), A. Løkke (Vejle, Denmark), S. Burhan Shaker (Gentofte, Denmark), O. Hilberg (Vejle, Denmark)
| |
Prevalence of respiratory viruses in COPD exacerbations: A meta-analysis
A. Mathioudakis (Manchester, United Kingdom), A. Kefala (Athens, Greece), G. Alimani (Athens, Greece), V. Chatzimavridou-Grigoriadou (Manchester, United Kingdom), N. Papadopoulos (Manchester, United Kingdom), A. Beloukas (Athens, Greece), J. Vestbo (Manchester, United Kingdom)
| |
Among both men and women with COPD ever-smokers have higher disease burden and worse prognosis than never-smokers
S. Lindberg (Boden, Sweden), E. Szakacs (Luleå, Sweden), C. Stridsman (Luleå, Sweden), S. Sawalha (Boden, Sweden), U. Nilsson (Umeå, Sweden), L. Hedman (Luleå, Sweden), E. Rönmark (Luleå, Sweden), H. Backman (Luleå, Sweden)
| |
A descriptive cross-sectional study on prevalence of respiratory diseases among patients visiting Jiri District Hospital, Nepal.
K. Paudel (Kathmandu, Nepal), T. Adhikari (Aarhus, Denmark), D. Rijal (Kathmandu, Nepal), B. Kalauni (Kathmandu, Nepal), B. Aryal (Kathmandu, Nepal), R. Paudel (Kathmandu, Nepal), M. Gaihre (Kathmandu, Nepal), S. Devkota (Kathmandu, Nepal)
| |
Prevalence of and factors associated with respiratory symptoms among patients with inflammatory bowel disease: a prospective study
B. Renel (Vandoeuvre-lès-Nancy, France), S. Valentin (Vandoeuvre-lès-Nancy, France), F. Manneville (Nancy, France), B. Caron (Vandoeuvre-lès-Nancy, France), M. Choukour (Nancy, France), A. Guillaumot (Vandoeuvre-lès-Nancy, France), A. Chaouat (Vandoeuvre-lès-Nancy, France), M. Poussel (Nancy, France), T. Chateau (Vandoeuvre-lès-Nancy, France), C. Peyrin-Biroulet (Vandoeuvre-lès-Nancy, France), H. Achit (Nancy, France), L. Peryin-Biroulet (Vandoeuvre-lès-Nancy, France), F. Chabot (Vandoeuvre-lès-Nancy, France)
| |
Comparative study of smoking and non-smoking chronic obstructive pulmonary disease.
A. Verma (Lucknow (Uttar Pradesh), India), A. Pandey (Lucknow (Uttar Pradesh), India), A. Singh (Lucknow (Uttar Pradesh), India), S. Kant (Lucknow (Uttar Pradesh), India), V. Prakash (Lucknow (Uttar Pradesh), India), R. Dixit (Lucknow (Uttar Pradesh), India), U. Singh (Lucknow (Uttar Pradesh), India), S. Chaudhari (Lucknow (Uttar Pradesh), India), A. Mandal (Lucknow (Uttar Pradesh), India), N. Dikshit (Lucknow, India)
| |
Trends in burden of COPD in Saudi Arabia
J. Alqahtani (Dammam, Saudi Arabia)
| |
Prevalence of respiratory viruses in stable COPD: A meta-analysis
A. Mathioudakis (Manchester, United Kingdom), A. Kefala (Athens, Greece), G. Alimani (Athens, Greece), V. Chatzimavridou-Grigoriadou (Manchester, United Kingdom), N. Papadopoulos (Manchester, United Kingdom), A. Beloukas (Athens, Greece), J. Vestbo (Manchester, United Kingdom)
| |
The disease burden and quality of life of chronic cough patients in South Korea and Taiwan
W. Song (Seoul, Republic of Korea), C. Yu (Taipei, Taiwan), S. Kang (Seoul, Republic of Korea)
| |
PERSISTING SYMPTOMS IN A COHORT OF 1966 SUBJECTS WITH SARS-COV-2 INFECTION: 1 YEAR FOLLOW-UP
O. Caguana Vélez (Barcelona, Spain), M. Cumpli Gargallo (Barcelona, Spain), M. Comas serrano (Barcelona, Spain), M. Posso Rivera (Barcelona, Spain), X. Duran Jordà (Barcelona, Spain), E. Balcells Vilarnau (Barcelona, Spain), M. Admetllo Papiol (Barcelona, Spain), A. Herranz Blasco (Barcelona, Spain), J. Villar Garcia (Barcelona, Spain), D. Badenes Bonet (Barcelona, Spain)
| |
Burden of chronic respiratory diseases in population in four South/South-East Asian low-and middle-income countries (LMICs).
D. Agarwal (Pune, India), N. Hanafi (Kuala Lumpur, Malaysia), E. Khoo (Kuala Lumpur, Malaysia), R. Parker (Edinburgh, United Kingdom), D. Ghorpade (Pune, India), S. Salvi (Pune, India), A. Bakar (Kuala Lumpur, Malaysia), K. Chinna (Kuala Lumpur, Malaysia), D. Das (Vellore, India), M. Habib (Khulna, Bangladesh), N. Hussein (Kuala Lumpur, Malaysia), R. Isaac (Vellore, India), M. Islam (Dhaka, Bangladesh), M. Khan (Islamabad, Pakistan), S. Liew (Kuala Lumpur, Malaysia), Y. Pang (Kuala Lumpur, Malaysia), B. Paul (Vellore, India), S. Saha (Dhaka, Bangladesh), L. Wong (Kuala Lumpur, Malaysia), O. Yusuf (Islamabad, Pakistan), S. Yusuf (Islamabad, Pakistan), S. Juvekar (Pune, India), H. Pinnock (Edinburgh, United Kingdom), B. PAUL (Vellore, India)
| |
Epidemiology and healthcare impact of IPF in Ontario from 2013-17.
S. Tang (Kingston, Canada), O. Morán-Mendoza (Kingston, Canada), S. Khan (Kingston, Canada), A. Johnson (Kingston, Canada)
| |